These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14663812)

  • 1. The expression of apoptotic proteins and matrix metalloproteinases in odontogenic myxomas.
    Bast BT; Pogrel MA; Regezi JA
    J Oral Maxillofac Surg; 2003 Dec; 61(12):1463-6. PubMed ID: 14663812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular review of odontogenic myxoma.
    Gomes CC; Diniz MG; Duarte AP; Bernardes VF; Gomez RS
    Oral Oncol; 2011 May; 47(5):325-8. PubMed ID: 21444236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIB-1, Bcl-2 and p53 in odontogenic myxomas of the jaws.
    Iezzi G; Piattelli A; Rubini C; Artese L; Fioroni M; Carinci F
    Acta Otorhinolaryngol Ital; 2007 Oct; 27(5):237-42. PubMed ID: 18198753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of matrix metalloproteinases 1, 2, and 9 in odontogenic myxoma and dental germ papilla.
    Nonaka CF; Augusto Vianna Goulart Filho J; Cristina da Costa Miguel M; Batista de Souza L; Pereira Pinto L
    Pathol Res Pract; 2009; 205(7):458-65. PubMed ID: 19243899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of proliferative markers in ameloblastomas and malignant odontogenic tumors.
    Otero D; Lourenço SQ; Ruiz-Ávila I; Bravo M; Sousa T; de Faria PA; González-Moles MA
    Oral Dis; 2013 May; 19(4):360-5. PubMed ID: 22970847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Roles of matrix metalloproteinases and tissue specific inhibitors of metalloproteinases in dentinogenic ghost cell tumor and ghost cell odontogenic carcinoma].
    Geng N; Ban Y; Chen Y; Yang MZ; Bao DM; Yi XZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Dec; 43(12):756-60. PubMed ID: 19134356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunolocalization of VEGF-A and orosomucoid-1 in odontogenic myxoma.
    Bologna-Molina R; Mosqueda-Taylor A; Domínguez-Malagón H; Salazar-Rodríguez S; Tapia G; Gónzalez-Gónzalez R; Molina-Frechero N
    Rom J Morphol Embryol; 2015; 56(2):465-73. PubMed ID: 26193215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Odontogenic myxoma: clinico-pathological, immunohistochemical and ultrastructural findings of a multicentric series.
    Martínez-Mata G; Mosqueda-Taylor A; Carlos-Bregni R; de Almeida OP; Contreras-Vidaurre E; Vargas PA; Cano-Valdéz AM; Domínguez-Malagón H
    Oral Oncol; 2008 Jun; 44(6):601-7. PubMed ID: 17996487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of CD-105 as an Angiogenic Modulator in Odontogenic Myxomas and Dental Follicles.
    Del Carmen González-Galván M; Aguirre-Urizar JM; Bologna-Molina R; Farfán-Morales JE; Gainza-Cirauqui ML; Marichalar-Mendia X; Mosqueda-Taylor A
    Int J Surg Pathol; 2016 Jun; 24(4):315-9. PubMed ID: 26888956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Odontogenic Myxomas Harbor Recurrent Copy Number Alterations and a Distinct Methylation Signature.
    Kleijn TG; Ameline B; Schreuder WH; Kooistra W; Doff JJ; Witjes M; Pichardo SEC; Lausová T; Koppes SA; van den Hout MFCM; van Engen-van Grunsven ICH; Flucke UE; de Lange J; Szuhai K; Briaire-de Bruijn IH; Savci-Heijink DC; Suurmeijer AJH; Bovée JVMG; von Deimling A; Baumhoer D; Cleven AHG
    Am J Surg Pathol; 2024 Oct; 48(10):1224-1232. PubMed ID: 39289817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two relatively distinct patterns of ameloblastoma: an anti-apoptotic proliferating site in the outer layer (periphery) and a pro-apoptotic differentiating site in the inner layer (centre).
    Sandra F; Nakamura N; Mitsuyasu T; Shiratsuchi Y; Ohishi M
    Histopathology; 2001 Jul; 39(1):93-8. PubMed ID: 11454049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin, cyclin D1, and p21hras in keratocystic odontogenic tumors before and after decompression.
    Brajić I; Škodrić S; Milenković S; Tepavčević Z; Soldatović I; Čolić S; Milašin J; Andrić M
    Oral Dis; 2016 Apr; 22(3):220-5. PubMed ID: 26662564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression and activity of matrix metalloproteinases characterize embolic cardiac myxomas.
    Orlandi A; Ciucci A; Ferlosio A; Pellegrino A; Chiariello L; Spagnoli LG
    Am J Pathol; 2005 Jun; 166(6):1619-28. PubMed ID: 15920147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Odontogenic myxoma: a clinicopathological study in a South African population.
    Titinchi F; Hassan BA; Morkel JA; Nortje C
    J Oral Pathol Med; 2016 Sep; 45(8):599-604. PubMed ID: 26822069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinases 2 and 9 in odontogenic myxoma in vivo and in vitro.
    Miyagi SP; Hiraki KR; Martins MD; Marques MM
    J Oral Sci; 2008 Jun; 50(2):187-92. PubMed ID: 18587209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and cell proliferation evaluation of ameloblastomas and keratocystic odontogenic tumors: a 10 year retrospective study.
    da Silva LP; Serpa MS; Santana T; do Nascimento GJ; de Souza Andrade ES; Sobral AP
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1089-1095. PubMed ID: 27747382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral odontogenic myxoma.
    Tasnime S; Saxena C; Bansal V; Wadhwan V
    Indian J Dent Res; 2016; 27(4):437-440. PubMed ID: 27723644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the osteoclastogenic process associated with RANK / RANK-L / OPG in odontogenic myxomas.
    González-Galván MC; Mosqueda-Taylor A; Bologna-Molina R; Setien-Olarra A; Marichalar-Mendia X; Aguirre-Urizar JM
    Med Oral Patol Oral Cir Bucal; 2018 May; 23(3):e315-e319. PubMed ID: 29680857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myxoma of the jaws. Report of three cases.
    Hernández Vallejo G; Cohn C; García Peñín A; Martínez Lara S; Llanes Menéndez F; Montalvo Moreno JJ
    Med Oral; 2001; 6(2):106-13. PubMed ID: 11500627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerosing odontogenic carcinoma: a previously unreported variant of a locally aggressive odontogenic neoplasm without apparent metastatic potential.
    Koutlas IG; Allen CM; Warnock GR; Manivel JC
    Am J Surg Pathol; 2008 Nov; 32(11):1613-9. PubMed ID: 18753945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.